Abstract Library

#4247 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia - A case report

Introduction: Idiopathic Diffuse Neuroendocrine Diffuse Neuroendocrine Hyperplasia is a rare, but increasingly recognized entity that primarily affects middle-aged and elderly women, Of available therapies, somatostatin analogs and mTOR are the most promising

Conference:

Presenting Author: Florez A

Authors: Florez A, Unigarro M, Fernandez J, Viola L, Perez G,

Keywords: neuroendocrine tumor, lung, idiopathic diffuse neuroendocrine hyperplasia, tumorlets,

#4235 Tricuspid valve replacement and liver transplantation in a 51-year-old female patient with grade 1 ileum NET and refractory carcinoid syndrome

Introduction: Refractory carcinoid syndrome (RCSy) could lead to severe complications.

Conference:

Presenting Author: Tőke J

Authors: Tőke J, Kövesdi A, Szolnoky J, Huszty G, Piros L,

Keywords: refractory carcinoid syndrome, liver transplantation, ileum neuroendocrine tumor,

#4058 Carcinoid syndrome caused by pulmonary neuroendocrine tumor liver metastases: A case report

Introduction: Neuroendocrine tumors (NETs) comprise a heterogeneous groups of maliganancies that arise from neuroencrine cells throughout the body and most commonly originate from the small intestine, lung,and rectum. Pulmonary NETs originate from pulmonary neuroendocrine cells that occur as individual cells or small pulmonary neuroendocrine cell. Although carcinoid tumors are considered low or intermediate-grade tumors, they metastasize to regional lymph nodes and distant organs, and the most common sites metastases are the liver and bone.

Conference:

Presenting Author: Tang Y

Authors: Tu R, Tang Y, Wang Y, Zhu Y, Kui X,

Keywords: pulmonary neuroendocrine tumor, liver metastases, Transcatheter Arterial Embolization, chemotherapy,

#3937 Gender differences in lung neuroendocrine tumors: A single center experience

Introduction: Lung neuroendocrine tumors (L-NET) are the second most common NET. No consistent data are available about gender difference due to their low prevalence.

Conference:

Presenting Author:

Authors: Liccardi A, Minotta R, Cannavale G, Benevento E, Di Iasi G,

Keywords: Lung neuroendocrine tumor, gendere differences, survival, risk factors, carcinoid tumor,

#3812 Validation of NEP-D score as a prognostic index in bronchial carcinoid tumors

Introduction: The development of prognostic scores able to classify patients with Bronchial Carcinoid (BC) according to clinical outcomes may help guide treatment selection. The NEP- score was found to be useful to stratify survival probability in patients with well-differentiated neuroendocrine neoplasms (NENs). According to multiple factors (age, primary tumor site, presence of metastasis, Ki-67, presence of functioning status and prior surgical removal of the primary tumor) NEP- score stratifies patients into different risk groups. The NEP-score at diagnosis (NEP-D score) is a derived score that could be calculated at diagnosis and does not consider the appearance of new metastases during follow-up.

Conference:

Presenting Author:

Authors: Medici M, Gagliardi I, Zanata I, Borges de Souza P, Ambrosio M,

Keywords: Bronchial Carcinoid, Neuroendocrine neoplasm, NEP-Score, Prognosis, Survival,